top
Search terms
Results 1 - 10 of 157 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 16
Escardio

Introduction This year, at the annual meeting of the European Society of Cardiology, there were 6,627 scientific contributions in a total of six Hot Line sessions, 13 Late Breaking Science sessions ...

Date : 20/11/2019
ESC365

Effects of EDOXaban on the cellular and protein phase of coagulation in coronary artery disease patients on dual antiplatelet therapy with aspirin and clopidogrel: a randomized pharmacodynamic study

Date : 02/09/2019
Escardio

Professor Deepak L. Bhatt (Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA) describes the rationale for the study, which is the largest trial in type 2 ...

Date : 02/09/2019
Escardio

The combination of ticagrelor and aspirin reduces ischaemic events compared with aspirin alone in patients with stable coronary artery disease and diabetes. Senior author Professor Deepak L. Bhatt ...

Date : 01/09/2019
Escardio

Senior author Professor Philippe Gabriel Steg of Hospital Bichat, Paris, France said: “Treatment with ticagrelor and aspirin also increased major bleeding relative to aspirin alone, but there ...

Date : 01/09/2019
Ehjcardiovascrec

The last three decades have seen significant advances in interventional and pharmacologic therapy for coronary artery disease (CAD). COX-1 is completely inhibited in over 99% of patients;1 however, ...

Cardiovascular Research, Friede, Kevin A, Voora, Deepak

Date : 01/08/2019 Item size : 134905 bytes
Escardio

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS The Task Force for dual antiplatelet therapy in coronary artery disease of the ...

Date : 26/03/2019
Ehjournal

When revisiting recommendations of previous guidelines, it was decided to take a cautious conservative position. [...]previous recommendations remained unchanged unless amendment was mandated by ...

European Heart Journal, Neumann, Franz-Josef, Sousa-Uva, Miguel

Date : 07/11/2018 Item size : 107310 bytes
Escardio

Clinical Presentation Topic Session Title Slides Webcast coronary artery disease, acute coronary syndromes, acute cardiac care Optimal antithrombotic treatment in the first year post PCI for ACS ...

Date : 14/09/2018
Escardio

The investigator-initiated, randomised, open-label GLOBAL LEADERS trial included almost 16,000 patients scheduled to undergo percutaneous coronary intervention for stable coronary artery disease ...

Date : 28/08/2018